Introduction: Cerebral palsy (CP) describes a group of permanent disorders of movement and posture, causing activity limitation, attributed to a non-progressive disorder that occurs in the developing brain. The family of a child with CP becomes essential and will be much in demand, both to drive the child's development in a favourable environment and to maintain his health. A well-functioning family and a variety of environmental stimuli can be decisive in supporting children with CP.
Objective: To define the prevalence of adverse outcomes according to the gestational age of maternal infection in a large cohort of ZIKV-infected Brazilian women and their infants. Design: Prospective, population-based cohort study. Setting: Ribeirão Preto's region private and public health facilities. Population: All pregnant women with confirmed ZIKV-infection and their infants. Methods: Prenatal/early neonatal data were obtained for all pairs. A subgroup of infants had cranial ultrasonography, eye fundoscopy, hearing, neurological exam, and Bayley III screening test within 3 months of age. Main Outcome Measures: Prevalence of pregnancy losses, anomalies detected at birth or within 3 months according to the gestational age of infection. Results: 511 women with ZIKV were identified from a total of 1116 women with flavivirus-type symptoms. Pregnancy losses 24/511(4.7%) and/or ZIKV-related anomalies occurred in 43/511(8.4%) mothers. Microcephaly or other CNS malformations were diagnosed in 1/4(25.0%) of the stillbirths and 19/489[3.9%;CI95%:2.5-5.9] of the live-born infants, with 13/513[2.5%;CI95%:1.5-4.3] neonates presenting major signs of CZS. Fetal abnormalities were 14.0(CI95%:7.6-26.0) times more likely with gestational infection <11 weeks. Among 280 asymptomatic evaluated infants, 2/155(1.3%) had eye abnormalities, 1/207(0.5%) CNS imaging significant findings, and 16/199(8%) neurological alert signs. Conclusions: This prospective, population-based study represents the largest Brazilian cohort of ZIKV in pregnancy. Congenital anomalies potentially associated with CZS are less frequent than previously thought. There is a strong relationship between the gestational age of infection (<11 weeks) and worse early infant prognosis. A notable proportion of apparently asymptomatic newborns can present with subclinical findings within 3 months of age. Funding: FAEPA/SES-SP Manuscript title: Early maternal Zika infection predicts severe neonatal neurological damage: results from the prospective Natural History of ZIKA Virus Infection in Gestation (NATZIG) cohort study.
O objetivo foi descrever como a não aderência ao tratamento fonoaudiológico em um caso de disfagia na encefalopatia crônica não progressiva pode levar a pneumonias de repetição. É seguida no HCPR uma criança, atualmente com cinco anos de idade, com diagnóstico de encefalopatia crônica não progressiva e disfagia desde o nascimento, com episódios repetidos de pneumonia cuja mãe não seguia as orientações terapêuticas determinadas pela fonoaudióloga. Na videofluoroscopia foi observada aspiração com a consistência liquida e não com a pastosa. Foi indicada gastrostomia para alimentação e hidratação, sendo permitida a ingestão via oral da consistência pastosa. A família não seguiu as orientações indicadas, a criança continuou ingerindo líquidos por via oral e, sendo assim, teve vários episódios de pneumonia. Embora a mãe tenha sido orientada a não fornecer alimentação líquida por via oral e sim pela gastrostomia, tal orientação não foi seguida, sem motivo aparente para que tal fato ocorresse. Fica evidente a importância da aderência familiar às orientações terapêuticas para que sejam evitadas complicações pulmonares decorrentes da aspiração de alimentos.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.